Literature DB >> 22036219

Common etiologies of neonatal pleural effusion.

Yueh-Ting Shih1, Pen-Hua Su, Jia-Yuh Chen, Inn-Chi Lee, Jui-Ming Hu, Hua-Pin Chang.   

Abstract

BACKGROUND: Pleural effusion is rare and includes several disease entities in the neonatal period. The aim of this study was to investigate the etiology, management, and outcome of neonatal pleural effusions.
METHODS: We retrospectively collected all neonates who were admitted to the neonatal intensive care unit of Chung Shan Medical University Hospital, Taichung, Taiwan, with discharge diagnosis of pleural effusion, chylothorax, hydrothorax, hemothorax, and empyema, from January 1999 to December 2009. The characteristics, etiology, management, and outcome were analyzed.
RESULTS: There were 21 patients identified, 16 males (76%) and 5 females (24%). Eight patients (38%) had primary and 13 patients (62%) had secondary etiologies. The etiologies included four parapneumonic effusions or empyema (19%); nine chylothorax (42.8%) with four congenital and five iatrogenic after thoracic surgery; three percutaneously inserted central venous catheter extravasation (14%); one umbilical venous catheter extravasation (4.7%); three hydrops fetalis (14%); and one congestive heart failure (4.7%). Fifteen patients (71%) needed chest tube placement. Conservative management with complete cessation of enteral feedings and use of total parenteral nutrition followed with infant formula containing medium-chain triglyceride was successful in six of the patients (67%) with chylothorax. There were two patients (22%) with chylothorax who received somatostatin administration; one was successful and the other one failed. Thoracic duct ligation was performed uneventfully in two patients with acquired chylothorax. There were three mortalities (14.3%) in this study, which were related to causes other than pleural effusion.
CONCLUSIONS: Pleural effusions in the neonatal stage may result from chylothorax, hydrops fetalis, extravasation of percutaneously inserted central venous catheter, parapneumonic effusion, congestive heart failure, or other less frequently occurring conditions. Diagnostic chest tap is required for subsequent management. Good outcome is the rule except in hydrops fetalis, which carries high mortality rate.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 22036219     DOI: 10.1016/j.pedneo.2011.06.002

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  5 in total

Review 1.  Fetal pleural effusion and Down syndrome.

Authors:  Li Cao; Yan Du; Ling Wang
Journal:  Intractable Rare Dis Res       Date:  2017-08

2.  Evaluating the Use of Octreotide for Acquired Chylothorax in Pediatric Critically Ill Patients Following Cardiac Surgery.

Authors:  Annie Bui; Courtney J Long; Robin L Breitzka; Joshua S Wolovits
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Sep-Oct

3.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

Review 4.  Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review.

Authors:  A C Jenkinson; J McGuinness; T Prendiville
Journal:  Pediatr Cardiol       Date:  2022-10-18       Impact factor: 1.838

5.  Perforations associated with peripherally inserted central catheters in a neonatal population.

Authors:  Andrew J Sertic; Bairbre L Connolly; Michael J Temple; Dimitri A Parra; Joao G Amaral; Kyong-Soon Lee
Journal:  Pediatr Radiol       Date:  2017-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.